Free Trial

Fennec Pharmaceuticals (FRX) Competitors

Fennec Pharmaceuticals logo
C$5.65 -0.45 (-7.38%)
(As of 11/15/2024 ET)

FRX vs. ABT, NOT, PYR, NVO, DNA, SLS, VBV, CUS, AIM, and APM

Should you be buying Fennec Pharmaceuticals stock or one of its competitors? The main competitors of Fennec Pharmaceuticals include Absolute Software Co. (ABT.TO) (ABT), Noront Resources (NOT), PyroGenesis Canada Inc. (PYR.V) (PYR), Novo Resources Corp. (NVO.V) (NVO), Dalradian Resources (DNA), Solaris Resources (SLS), VBI Vaccines (VBV), Chemtrade Electrochem Inc, (CUS), Aimia (AIM), and Andean Precious Metals (APM). These companies are all part of the "pharmaceutical products" industry.

Fennec Pharmaceuticals vs.

Absolute Software Co. (ABT.TO) (TSE:ABT) and Fennec Pharmaceuticals (TSE:FRX) are both small-cap computer and technology companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, community ranking, media sentiment, institutional ownership, valuation, dividends, risk, analyst recommendations and earnings.

Absolute Software Co. (ABT.TO) received 204 more outperform votes than Fennec Pharmaceuticals when rated by MarketBeat users. However, 69.59% of users gave Fennec Pharmaceuticals an outperform vote while only 67.77% of users gave Absolute Software Co. (ABT.TO) an outperform vote.

CompanyUnderperformOutperform
Absolute Software Co. (ABT.TO)Outperform Votes
307
67.77%
Underperform Votes
146
32.23%
Fennec PharmaceuticalsOutperform Votes
103
69.59%
Underperform Votes
45
30.41%

Absolute Software Co. (ABT.TO) has higher revenue and earnings than Fennec Pharmaceuticals. Absolute Software Co. (ABT.TO) is trading at a lower price-to-earnings ratio than Fennec Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Absolute Software Co. (ABT.TO)C$104.67M0.00C$10.04MC$0.24N/A
Fennec PharmaceuticalsC$48.89M3.16C$2.73MC$0.1056.50

Fennec Pharmaceuticals has a net margin of 5.59% compared to Absolute Software Co. (ABT.TO)'s net margin of 0.00%. Absolute Software Co. (ABT.TO)'s return on equity of 0.00% beat Fennec Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Absolute Software Co. (ABT.TO)N/A N/A N/A
Fennec Pharmaceuticals 5.59%-1,005.59%8.88%

52.8% of Fennec Pharmaceuticals shares are owned by institutional investors. 16.2% of Fennec Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, Fennec Pharmaceuticals had 3 more articles in the media than Absolute Software Co. (ABT.TO). MarketBeat recorded 4 mentions for Fennec Pharmaceuticals and 1 mentions for Absolute Software Co. (ABT.TO). Absolute Software Co. (ABT.TO)'s average media sentiment score of 0.00 beat Fennec Pharmaceuticals' score of -0.41 indicating that Absolute Software Co. (ABT.TO) is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Absolute Software Co. (ABT.TO)
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Fennec Pharmaceuticals
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Absolute Software Co. (ABT.TO) beats Fennec Pharmaceuticals on 7 of the 13 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FRX vs. The Competition

MetricFennec PharmaceuticalsBiotechnology IndustryMedical SectorTSE Exchange
Market CapC$154.58MC$150.91MC$5.16BC$6.08B
Dividend Yield2.02%3.64%5.18%5.33%
P/E Ratio56.50187.6768.5626.33
Price / Sales3.1616,673.191,271.871,427.12
Price / Cash11.6612.4639.7182.02
Price / Book-113.007.886.483.06
Net IncomeC$2.73M-C$20.05MC$119.82MC$291.48M
7 Day Performance-5.52%7.83%-5.13%-0.14%
1 Month Performance-11.72%11.90%-2.71%-1.45%
1 Year Performance-50.00%31.41%31.10%42.59%

Fennec Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FRX
Fennec Pharmaceuticals
N/AC$5.65
-7.4%
N/A-48.7%C$154.58MC$48.89M56.5010
ABT
Absolute Software Co. (ABT.TO)
N/AN/AN/AN/AC$636.46MC$104.67M63.42115,000High Trading Volume
NOT
Noront Resources
N/AC$1.10
-0.5%
N/A+0.0%C$612.18MN/A-7.20101,700
PYR
PyroGenesis Canada Inc. (PYR.V)
N/AC$3.85
+11.0%
N/A+0.0%C$606.96MC$6.01M-154.0090Gap Up
NVO
Novo Resources Corp. (NVO.V)
N/AC$2.38
-0.4%
N/A+0.0%C$548.24MN/A-21.2554,400
DNA
Dalradian Resources
N/AN/AN/AN/AC$519.02MN/A-56.15640News Coverage
SLS
Solaris Resources
1.7365 of 5 stars
C$3.19
-2.1%
N/A-34.2%C$517.55MN/A-7.0910
VBV
VBI Vaccines
N/AN/AN/AN/AC$308.86MC$3.36M-4.9722
CUS
Chemtrade Electrochem Inc,
N/AN/AN/AN/AC$306.50MN/A0.0060
AIM
Aimia
1.8636 of 5 stars
C$2.61
+0.4%
N/A-12.4%C$256.77MC$396.20M-1.9620
APM
Andean Precious Metals
1.6489 of 5 stars
C$1.41
-2.8%
N/AN/AC$210.60MC$199.84M3.7130Analyst Revision
Gap Up

Related Companies and Tools


This page (TSE:FRX) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners